ONMD

$0.76

Market ClosedAs of Mar 17, 8:00 PM UTC

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.76
Potential Upside
5%
Whystock Fair Value$0.80
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinic...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$38.97M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.09
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.15

Recent News

Associated Press Finance
Feb 27, 2026

BC-Most Active Stocks

Elong Power Holding Ltd. 27,481,598 0.1358

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Oct 16, 2025

Is Palantir (PLTR) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies

Palantir Technologies, Inc. (NASDAQ:PLTR) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On October 6, OneMedNet Corporation announced a multi-year partnership with Palantir Technologies (NASDAQ;PLTR) to transform healthcare AI and Real-World Data (RWD) analytics. Palantir’s Artificial Intelligence Platform will power OneMedNet’s iRWD network, enabling life sciences and research organizations […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Oct 16, 2025

Palantir Taps Healthcare AI Growth with OneMedNet Partnership

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the fastest-growing AI stocks to invest in now. OneMedNet officially announced on October 6, 2025 that it had selected Palantir Technologies Inc. (NASDAQ:PLTR) to enhance its offerings in healthcare AI and real-world data analytics, linking its provider network with Palantir’s platform. The companies say the collaboration will integrate […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Oct 13, 2025

Palantir Technologies (PLTR): Evaluating Valuation as Healthcare Deal Expands Its AI Platform’s Market Reach

Palantir Technologies is stepping up its healthcare ambitions through a new multi-year agreement with OneMedNet, bringing its Artificial Intelligence Platform to the forefront of transforming how clinical data is accessed and analyzed. This move expands Palantir's footprint well beyond its roots in government work and targets scalable, recurring revenue opportunities across healthcare and life sciences. See our latest analysis for Palantir Technologies. After an incredible run that saw its...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Oct 8, 2025

A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI Data

OneMedNet (ONMD) is making headlines after announcing a strategic partnership with Medcase, a global leader in medical data annotation. This collaboration brings OneMedNet into the expanding healthcare AI data market and offers recurring revenue potential alongside its core platform. See our latest analysis for OneMedNet. Following the news of its Medcase partnership, OneMedNet’s momentum has become hard to ignore. The shares have surged with a staggering 199% share price return over the past...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.